In the Original Investigation titled “Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: a Secondary Analysis of a Randomized Clinical Trial,”1 published in the September 2016 issue of JAMA Otolaryngology–Head & Neck Surgery, conflict of interest disclosures were not reported accurately by José Baselga, MD, PhD. Dr Baselga has written a Letter to the journal2 explaining this inconsistent reporting of potential conflict of interest disclosures. This article was corrected online.
References
- 1.Bonner J, Giralt J, Harari P, et al. . Cetuximab and radiotherapy in laryngeal preservation for cancers of the larynx and hypopharynx: a secondary analysis of a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2016;142(9):842-849. doi: 10.1001/jamaoto.2016.1228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Baselga J. Failure to accurately disclose conflicts of interest in article published in JAMA Otolaryngology–Head & Neck Surgery [published online October 26, 2018]. JAMA Otolaryngol Head Neck Surg. doi: 10.1001/jamaoto.2018.3400 [DOI] [PubMed] [Google Scholar]